DIANA Biotechnologies is a biotech company that provides innovative solutions across the biotech sector, including diagnostic and academic labs, monoclonal antibody development, and drug discovery services. The company's core business involves the development and production of PCR and RT-PCR products, custom oligonucleotide synthesis, and comprehensive kinase inhibitor profiling services. They also offer a range of products, including ultrasensitive sepsis diagnostics, RNase inhibitors, and reverse transcriptase. Additionally, the company provides services such as monoclonal antibody development and drug discovery, leveraging their expertise in medical and organic chemistry, biochemistry, and pharmacology to drive healthcare advancements.

DIANA Biotechnologies is a Czech biotech company that advances research and development. Powered by a team of top scientists in molecular biology, chemistry, pharmacology, and automation, we provide R&D services and products for academic labs, biotech companies, and pharmaceutical partners. Our offerings include the development of monoclonal antibodies, engineered PCR enzymes and drug discovery services.

DIANA Biotechnologies delivers ready-to-use PCR mixes, innovative enzymes, and proteins designed for reliable and high-performance molecular testing. In addition to products for end-users, we also provide OEM and white-label production as well as fully customized solutions.

We offer monoclonal antibody development tailored to research, diagnostic, and therapeutic applications.

Our drug discovery services include high-throughput screening (HTS) platforms and assay development to accelerate pharmaceutical innovation.